> top > docs > PMC:3586680 > spans > 166-281 > annotations

PMC:3586680 / 166-281 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T594 89-106 JJ denotes domain-containing
T593 86-88 NNP denotes WW
T592 84-85 . denotes .
T591 79-84 NNS denotes drugs
T590 67-78 JJ denotes therapeutic
T589 63-66 CC denotes and
T588 61-62 -RRB- denotes )
T587 58-61 NNP denotes TMZ
T586 57-58 -LRB- denotes (
T585 44-56 VB denotes temozolomide
T584 41-43 TO denotes to
T583 30-40 NN denotes resistance
T582 27-29 TO denotes to
T581 25-26 , denotes ,
T580 21-25 NN denotes part
T579 18-20 IN denotes in
T578 16-17 , denotes ,
T577 6-16 VB denotes contribute
T576 3-5 TO denotes to
R289 T576 T577 aux to,contribute
R291 T578 T577 punct ",",contribute
R293 T580 T579 pobj part,in
R295 T582 T583 aux to,resistance
R297 T584 T585 aux to,temozolomide
R298 T585 T583 advcl temozolomide,resistance
R299 T586 T587 punct (,TMZ
R300 T587 T585 appos TMZ,temozolomide
R301 T588 T587 punct ),TMZ
R302 T589 T585 cc and,temozolomide
R303 T590 T591 amod therapeutic,drugs
R304 T591 T585 conj drugs,temozolomide

bionlp-st-ge-2016-test-ihmc

Id Subject Object Predicate Lexical cue
T535 44-62 Entity denotes temozolomide (TMZ)
T526 67-84 Entity denotes therapeutic drugs
T523 58-61 Entity denotes TMZ

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T207 89-106 JJ denotes domain-containing
T206 86-88 JJ denotes WW
T205 79-84 NN denotes drugs
T204 67-78 JJ denotes therapeutic
T203 63-66 CC denotes and
T202 61-62 -RRB- denotes )
T201 58-61 NN denotes TMZ
T200 57-58 -LRB- denotes (
T199 44-56 NN denotes temozolomide
T198 41-43 TO denotes to
T197 30-40 NN denotes resistance
T196 27-29 TO denotes to
T195 25-26 -COMMA- denotes ,
T194 21-25 NN denotes part
T193 18-20 IN denotes in
T192 16-17 -COMMA- denotes ,
T191 6-16 VB denotes contribute
T190 3-5 TO denotes to
R54 T191 T190 arg1Of contribute,to
R55 T191 T192 arg1Of contribute,","
R56 T191 T193 arg1Of contribute,in
R57 T191 T195 arg1Of contribute,","
R58 T191 T196 arg1Of contribute,to
R59 T194 T193 arg2Of part,in
R60 T197 T198 arg1Of resistance,to
R61 T197 T203 arg1Of resistance,and
R62 T199 T198 arg2Of temozolomide,to
R63 T199 T200 arg1Of temozolomide,(
R64 T201 T200 arg2Of TMZ,(
R65 T202 T200 arg3Of ),(
R66 T203 T196 arg2Of and,to
R67 T205 T203 arg2Of drugs,and
R68 T205 T204 arg1Of drugs,therapeutic